LONDON--(BUSINESS WIRE)--April 20, 2005--IMS Health (NYSE:RX), the world’s leading provider of information solutions to the pharmaceutical and healthcare industries, today announced an agreement to collaborate with GlaxoSmithKline (GSK) on a programme to improve management of sales force information in GSK’s pharmaceuticals business in Europe. The financial terms of the agreement were not disclosed. “We are pleased to strengthen our long-standing relationship with GSK and to support them in this significant engagement,” said Gilles Pajot, IMS executive vice president and president, IMS EMEA Region. “In today’s competitive and complex marketplace, pharmaceutical companies are looking to enhance the productivity of their sales teams and to deliver higher returns on investments in R&D and new products. IMS’s powerful combination of information, analytics and consulting capabilities will enable us to help GSK achieve its business objectives.”
